Exelixis (EXEL) Receivables (2012 - 2026)
Exelixis (EXEL) posted Receivables of $322.21 million for Q2 2027, up 10.2% from $292.35 million a year earlier but down 2.0% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2026, Exelixis' Receivables came in at $286.92 million, up 8.1% from FY2025.
- Annual Receivables shows a five-year compound annual growth rate of 0.3% (FY2021 to FY2026).
- In prior years, Exelixis' Receivables was $265.44 million in FY2025, $237.41 million in FY2023 (+10.5%) and $214.78 million in FY2022 (-24.0%).
- Quarterly Receivables has run from a low of $240.58 million in Q1 2025 to a high of $396.58 million in Q2 2025 over five years.
- On a year-over-year basis, Receivables has increased in each of the last four quarters, with growth averaging 6.8% over the last six quarters.
- According to Business Quant data, Receivables for the three prior quarters was $328.95 million (Q1 2027), $286.92 million (Q4 2026) and $309.73 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 322.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 322.21 Mn |
| Apr 3, 2026 | 328.95 Mn |
| Jan 2, 2026 | 286.92 Mn |
| Oct 3, 2025 | 309.73 Mn |
| Jul 4, 2025 | 292.35 Mn |
| Apr 4, 2025 | 281.64 Mn |
| Jan 3, 2025 | 265.44 Mn |
| Sep 27, 2024 | 269.71 Mn |
| Jun 28, 2024 | 396.58 Mn |
| Mar 29, 2024 | 240.58 Mn |
| Dec 29, 2023 | 237.41 Mn |
| Sep 29, 2023 | 248.11 Mn |
| Jun 30, 2023 | 232.82 Mn |
| Mar 31, 2023 | 233.92 Mn |
| Dec 30, 2022 | 214.78 Mn |
| Sep 30, 2022 | 215.02 Mn |
| Jul 1, 2022 | 235.40 Mn |
| Apr 1, 2022 | 190.61 Mn |
| Dec 31, 2021 | 282.65 Mn |
| Oct 1, 2021 | 179.49 Mn |
API Access
Exelixis Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();